Evolving profile and outcomes of patients with pulmonary arterial hypertension undergoing lung transplantation.

Fiche publication

Date publication

novembre 2026

Journal

JHLT open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr OLLAND Anne

Tous les auteurs :
Pradère P, Luong MC, Le Pavec J, Issard J, Coiffard B, Renard S, Boulate D, Renaud-Picard B, Olland A, Villeneuve T, Demant X, Maury JM, Chatron E, Mitilian D, Dauriat G, Boucly A, Sitbon O, Jaïs X, Montani D, Humbert M, Fadel E, Mercier O, Horeau-Langlard D, Savale L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42780297

Résumé

Despite major advances in targeted therapies, lung transplantation remains a key option for selected patients with end-stage pulmonary arterial hypertension (PAH) but is associated with substantial clinical and organizational challenges. Our aim was to describe the impact of changes in advanced PAH management and referral strategies on the profile of transplanted patients and outcomes.